Synthesis and biological evaluation of genistein-O-alkylamine derivatives as potential multifunctional anti-Alzheimer agents. 2019

Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
Huaihe Hospital, Henan University, Kaifeng, China.

A series of genistein derivatives were synthesized and evaluated as multifunctional anti-Alzheimer agents. The results showed that these derivatives had significant acetylcholinesterase (AChE) inhibitory activity; compound 5a exhibited the strongest inhibition to AChE with an IC50 value (0.034 μM) much lower than that of rivastigmine (6.53 μM). A Lineweaver-Burk plot and molecular modeling study showed that compound 5a targeted both the catalytic active site and the peripheral anionic site of AChE. These compounds also showed potent peroxy scavenging activity and metal-chelating ability. The compounds did not show obvious effect on HepG2 and PC12 cell viability at the concentration of 100 μM. Therefore, these genistein derivatives can be utilized as multifunctional agents for the treatment of AD.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous

Related Publications

Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
November 2023, Bioorganic chemistry,
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
August 2018, European journal of medicinal chemistry,
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
June 2017, Molecules (Basel, Switzerland),
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
March 2024, Anticancer research,
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
October 2016, European journal of medicinal chemistry,
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
November 2018, Chemical biology & drug design,
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
September 2016, Journal of medicinal chemistry,
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
April 2017, European journal of medicinal chemistry,
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
February 2018, Bioorganic & medicinal chemistry letters,
Chen Hong, and Hui-Yan Guo, and Shuai Chen, and Jian-Wu Lv, and Xin Zhang, and Ya-Cheng Yang, and Kang Huang, and Yi-Juan Zhang, and Zhi-Yong Tian, and Wen Luo, and Yi-Ping Chen
February 2018, Molecules (Basel, Switzerland),
Copied contents to your clipboard!